Alimera Sciences is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The company focuses on diseases related to eye. Its most popular product is Iluvien, which is used for the treatment of diabetic macular edema that is a disease of retina, which affects individuals with diabetes and can lead to severe vision loss and blindness. Alimera Sciences has an exclusive worldwide agreement with Emory University to explore oxidative stress management for the treatment of ophthalmic diseases. Its resources include the American Academy of Ophthalmology and the Joint Commission on Allied Health Personnel in Ophthalmology. The company is located in Alpharetta, Ga.